Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Victor

Showing results (411-420 of 438) with videos related to

Pageof 44
Sort By:
The Journal of Clinical Investigation|June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityKathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and HumansAaron S Devanathan, John K Fallon, Nicole R White, et al.
Molecular Biology of the Cell|July 26, 2013
Arp2/3 complex is essential for actin network treadmilling as well as for targeting of capping protein and cofilinStefan A Koestler, Anika Steffen, Maria Nemethova, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Plos One|September 9, 2010
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamicsMorgane Rolland, Jonathan M Carlson, Siriphan Manocheewa, et al.
Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.
Plos Pathogens|January 14, 2014
Targeted cytotoxic therapy kills persisting HIV infected cells during ARTPaul W Denton, Julie M Long, Stephen W Wietgrefe, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Bacterial natural transformation by highly fragmented and damaged DNASøren Overballe-Petersen, Klaus Harms, Ludovic A A Orlando, et al.
Nature Communications|September 22, 2019
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug deliveryS Rahima Benhabbour, Martina Kovarova, Clinton Jones, et al.
Nature Cell Biology|October 28, 2016
Diversified actin protrusions promote environmental exploration but are dispensable for locomotion of leukocytesAlexander Leithner, Alexander Eichner, Jan Müller, et al.
Pageof 44

Showing results (411-420 of 438) with videos related to

Sort By:
Pageof 44
The Journal of Clinical Investigation|June 15, 2023
An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityKathryn L Roche, Stacy Remiszewski, Matthew J Todd, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2020
Antiretroviral Penetration and Drug Transporter Concentrations in the Spleens of Three Preclinical Animal Models and HumansAaron S Devanathan, John K Fallon, Nicole R White, et al.
Molecular Biology of the Cell|July 26, 2013
Arp2/3 complex is essential for actin network treadmilling as well as for targeting of capping protein and cofilinStefan A Koestler, Anika Steffen, Maria Nemethova, et al.
Research Square|September 30, 2020
Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801Angela Wahl, Lisa Gralinski, Claire Johnson, et al.
Plos One|September 9, 2010
Amino-acid co-variation in HIV-1 Gag subtype C: HLA-mediated selection pressure and compensatory dynamicsMorgane Rolland, Jonathan M Carlson, Siriphan Manocheewa, et al.
Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.
Plos Pathogens|January 14, 2014
Targeted cytotoxic therapy kills persisting HIV infected cells during ARTPaul W Denton, Julie M Long, Stephen W Wietgrefe, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2013
Bacterial natural transformation by highly fragmented and damaged DNASøren Overballe-Petersen, Klaus Harms, Ludovic A A Orlando, et al.
Nature Communications|September 22, 2019
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug deliveryS Rahima Benhabbour, Martina Kovarova, Clinton Jones, et al.
Nature Cell Biology|October 28, 2016
Diversified actin protrusions promote environmental exploration but are dispensable for locomotion of leukocytesAlexander Leithner, Alexander Eichner, Jan Müller, et al.
Pageof 44